# Trade Mark Journal No.2026/011 13 March 2026

## UK00004344526 24 February 2026 (5,10,42,44)

FLS Laboratories

Class 5
  Medical diagnostic test kits comprised primarily of chemical reagents, assay preparations, buffers, and diagnostic preparations for in vitro testing of human blood, plasma, saliva, and urine for medical diagnostic purposes, namely, assessing organ function, organ health, biological organ age, fertility status, cancer biomarkers, and genetic conditions, all of the foregoing for at-home self-collection and authorized healthcare professional use .
Class 10
  Medical specimen collection kits comprised primarily of lancets, capillary blood collection devices, specimen collection tubes, swabs, cards, and containers, all for at-home self-collection and transport of human blood, plasma, saliva, and urine for medical diagnostic testing and authorised healthcare professional use; Medical test kits for taking samples and ordering and review of direct-to-consumer laboratory tests of various medical conditions .
Class 42
  Laboratory testing services; Medical laboratory services; Providing scientific analysis and information regarding the results of laboratory testing in the field of various medical conditions; Providing temporary use of non-downloadable software and software as a service (SaaS) featuring software for uploading, processing, analyzing, and displaying medical diagnostic laboratory test data derived from human blood, plasma, saliva, urine, and other human specimens; Providing temporary use of non-downloadable software for generating medical diagnostic reports and clinical decision support outputs based on proteomic, genomic, fertility, oncology, and organ function biomarkers for medical diagnostic purposes; Hosting an online platform featuring non-downloadable software for secure storage and transmission of medical test results to patients and healthcare professionals; Hosting an online platform featuring non-downloadable software for secure storage and transmission of medical test results direct-to-consumer .
Class 44
  Medical diagnostic testing, monitoring and reporting services; Providing medical test results and diagnostic interpretations to patients and healthcare professionals; Health care services, namely, ordering and review of direct-to-consumer laboratory testing; Genetic testing for medical purposes; Genetic testing for cancer risk for medical purposes; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood testing services in the nature of laboratory services for diagnostic purposes using at-home self-collected collection devices; Medical evaluation of cancer, infertility, and organ function based on medical laboratory test results; Structural and functional analysis of genomes for medical purposes; Urine analysis being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Providing medical test results and diagnostic interpretations to patients and healthcare professionals .

Fission Holdings Limited

Representative: Lawbright LTD